Journal of Cancer Therapy

Vol.6 No.1(2015), Paper ID 52674, 11 pages

DOI:10.4236/jct.2015.61001

 

Rituximab Improves Overall Survival in Patients Treated with CODOX-M/IVAC for Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and BL (BCL-U): A Single Center Experience and Review of the Literature

 

A. Prica, A. Pratzer, M. Cheung, K. Thompson, E. Piliotis, N. L. Berinstein, K. Imrie, R. Pradhan, A. Vyas, Z. Ghorab, D. Good, L. Zhang, R. Buckstein

 

Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Feinberg School of Medicine, Northwestern University, Chicago, USA
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Canada
Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Canada
Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Canada
Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Canada
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada

 

Copyright © 2015 A. Prica, A. Pratzer, M. Cheung, K. Thompson, E. Piliotis, N. L. Berinstein, K. Imrie, R. Pradhan, A. Vyas, Z. Ghorab, D. Good, L. Zhang, R. Buckstein et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Prica, A. , Pratzer, A. , Cheung, M. , Thompson, K. , Piliotis, E. , Berinstein, N. , Imrie, K. , Pradhan, R. , Vyas, A. , Ghorab, Z. , Good, D. , Zhang, L. and Buckstein, R. (2015) Rituximab Improves Overall Survival in Patients Treated with CODOX-M/IVAC for Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and BL (BCL-U): A Single Center Experience and Review of the Literature. Journal of Cancer Therapy, 6, 1-11. doi: 10.4236/jct.2015.61001.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.